Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shaowei Li

Showing results (381-390 of 405) with videos related to

Pageof 41
Sort By:
Cell Reports|June 19, 2026
Public antibody clonotypes and deep learning identify SARS-CoV-2 and HIV broadly neutralizing antibodies in immune repertoiresLizhi Zhou, Zhili Yu, Shutian Lin, et al.
Science Translational Medicine|January 14, 2026
An antibody cocktail targeting conserved, nonoverlapping epitopes prevents viral escape and confers protection against RSV in vivoYongpeng Sun, Liqin Liu, Zemin Jiang, et al.
Nature Communications|December 16, 2025
A broadly neutralizing antibody confers cross-genus protection against alphaherpesviruses by inhibiting gB-mediated membrane fusionGuosong Wang, Yu Li, Chongxin Wu, et al.
Protein & Cell|July 20, 2023
Two antibodies show broad, synergistic neutralization against SARS-CoV-2 variants by inducing conformational change within the RBDHui Sun, Tingting Deng, Yali Zhang, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 25, 2025
Broad neutralizing antibody response of a monomeric spike-based SARS-CoV-2 bivalent vaccine against diverse variantsSiling Wang, Hui Sun, Yizhen Wang, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 16, 2022
The neutralizing breadth of antibodies targeting diverse conserved epitopes between SARS-CoV and SARS-CoV-2Hualong Xiong, Hui Sun, Siling Wang, et al.
Med (New York, N.Y.)|August 1, 2024
Tumor microenvironment RNA test to predict immunotherapy outcomes in advanced gastric cancer: The TIMES001 trialMin Shi, Dongqiang Zeng, Huiyan Luo, et al.
Nature Communications|September 28, 2021
Cross-neutralizing antibodies bind a SARS-CoV-2 cryptic site and resist circulating variantsTingting Li, Wenhui Xue, Qingbing Zheng, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|October 29, 2025
Predicting Immunotherapy Outcomes in NSCLC Using RNA and Pathology from Multicenter Clinical TrialsZhaojun Wang, Yiran Fang, Xiatong Huang, et al.
Nature Microbiology|October 18, 2024
Broadly therapeutic antibody provides cross-serotype protection against enteroviruses via Fc effector functions and by mimicking SCARB2Rui Zhu, Yuanyuan Wu, Yang Huang, et al.
Pageof 41

Showing results (381-390 of 405) with videos related to

Sort By:
Pageof 41
Cell Reports|June 19, 2026
Public antibody clonotypes and deep learning identify SARS-CoV-2 and HIV broadly neutralizing antibodies in immune repertoiresLizhi Zhou, Zhili Yu, Shutian Lin, et al.
Science Translational Medicine|January 14, 2026
An antibody cocktail targeting conserved, nonoverlapping epitopes prevents viral escape and confers protection against RSV in vivoYongpeng Sun, Liqin Liu, Zemin Jiang, et al.
Nature Communications|December 16, 2025
A broadly neutralizing antibody confers cross-genus protection against alphaherpesviruses by inhibiting gB-mediated membrane fusionGuosong Wang, Yu Li, Chongxin Wu, et al.
Protein & Cell|July 20, 2023
Two antibodies show broad, synergistic neutralization against SARS-CoV-2 variants by inducing conformational change within the RBDHui Sun, Tingting Deng, Yali Zhang, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 25, 2025
Broad neutralizing antibody response of a monomeric spike-based SARS-CoV-2 bivalent vaccine against diverse variantsSiling Wang, Hui Sun, Yizhen Wang, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 16, 2022
The neutralizing breadth of antibodies targeting diverse conserved epitopes between SARS-CoV and SARS-CoV-2Hualong Xiong, Hui Sun, Siling Wang, et al.
Med (New York, N.Y.)|August 1, 2024
Tumor microenvironment RNA test to predict immunotherapy outcomes in advanced gastric cancer: The TIMES001 trialMin Shi, Dongqiang Zeng, Huiyan Luo, et al.
Nature Communications|September 28, 2021
Cross-neutralizing antibodies bind a SARS-CoV-2 cryptic site and resist circulating variantsTingting Li, Wenhui Xue, Qingbing Zheng, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|October 29, 2025
Predicting Immunotherapy Outcomes in NSCLC Using RNA and Pathology from Multicenter Clinical TrialsZhaojun Wang, Yiran Fang, Xiatong Huang, et al.
Nature Microbiology|October 18, 2024
Broadly therapeutic antibody provides cross-serotype protection against enteroviruses via Fc effector functions and by mimicking SCARB2Rui Zhu, Yuanyuan Wu, Yang Huang, et al.
Pageof 41